Show simple item record

dc.contributor.authorRadwan-Pragłowska, Julia
dc.contributor.authorJanus, Łukasz
dc.contributor.authorPiątkowski, Marek
dc.contributor.authorSierakowska, Aleksandra
dc.contributor.authorMatýsek, Dalibor
dc.date.accessioned2020-10-30T11:31:52Z
dc.date.available2020-10-30T11:31:52Z
dc.date.issued2020
dc.identifier.citationColloids and Surfaces B: Biointerfaces. 2020, vol. 194, art. no. 111170.cs
dc.identifier.issn0927-7765
dc.identifier.issn1873-4367
dc.identifier.urihttp://hdl.handle.net/10084/142375
dc.description.abstractThe growing number of people suffering from civilization diseases increases the amount of medication taken. Thus, novel methods for drug delivery must be developed which will constitute an alternative to oral administration. A new hope for patients bring transdermal drug delivery systems. To overcome skin barrier function, they must be prepared from materials which increase cell membrane permeability for the medication. Therefore, there is an increasing need for novel, advanced transdermal systems capable of controlled active substance release under specific stimuli. The aim of this research was to obtain novel hydrogel-based transdermal delivery systems through crosslinking process of chitosan using azelaic acid followed by doping with ZnO nanorods to enhance its drug sorption properties. Ready materials were investigated over their structure, morphology and durability. Drug loading capacity, controlled drug release ability and its kinetics were determined on medication used in treatment of cardiovascular system diseases-acetylsalicylic acid. Finally, lack of cytotoxicity was confirmed by XTT assay and cell morphology study carried out on L929 mouse fibroblasts. Obtained results show a great potential of the developed transdermal delivery systems in active substances administration through skin tissue and may help to protect digestive tract of the patients in the future.cs
dc.language.isoencs
dc.publisherElseviercs
dc.relation.ispartofseriesColloids and Surfaces B: Biointerfacescs
dc.relation.urihttp://doi.org/10.1016/j.colsurfb.2020.111170cs
dc.rights© 2020 The Authors. Published by Elsevier B.V.cs
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/cs
dc.subjectZnO nanoparticlescs
dc.subjectchitosan hydrogelscs
dc.subjectadvanced biomaterialscs
dc.subjectmicrowave-assisted synthesiscs
dc.subjectcontrolled drug releasecs
dc.titleZnO nanorods functionalized with chitosan hydrogels crosslinked with azelaic acid for transdermal drug deliverycs
dc.typearticlecs
dc.identifier.doi10.1016/j.colsurfb.2020.111170
dc.rights.accessopenAccesscs
dc.type.versionpublishedVersioncs
dc.type.statusPeer-reviewedcs
dc.description.sourceWeb of Sciencecs
dc.description.volume194cs
dc.description.firstpageart. no. 111170cs
dc.identifier.wos000564600500009


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2020 The Authors. Published by Elsevier B.V.
Except where otherwise noted, this item's license is described as © 2020 The Authors. Published by Elsevier B.V.